-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2010 to Q4 2023.
- Lexaria Bioscience Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending November 30, 2023 was $1.82M.
- Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.59M.
- Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$44.6K, a 100% decline from 2021.
- Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $13.4M, a 406% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)